# EDGAR Filing Document

**Accession Number:** 0001610820
**File Stem:** 0001493152-26-000961
**Filing Date:** 2026-1
**Character Count:** 2424
**Document Hash:** 4dfa1b501937dd71382b775d97cb1b22
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-000961.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001493152-26-000961

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260108

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BriaCell Therapeutics Corp.
- **CENTRAL INDEX KEY:** 0001610820
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0731

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
- **CITY:** WEST VANCOUVER
- **STATE:** A1
- **ZIP:** V7T 2X1
- **BUSINESS PHONE:** (604) 921-1810

**MAIL ADDRESS:**
- **STREET 1:** 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR
- **CITY:** WEST VANCOUVER
- **STATE:** A1
- **ZIP:** V7T 2X1

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Ansell Capital Corp.
- **DATE OF NAME CHANGE:** 20140613

**BriaCell Therapeutics Corp.**

**Suite 300 - 235 15th Street**

**West Vancouver, BC V7T 2X1**

January 8, 2026

**VIA EDGAR**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549

Attention: Daniel Crawford

---

| | |
|:---|:---|
| **Re:** | **BriaCell Therapeutics Corp. (the "Company")** |
|  | **Registration Statement on Form S-1 (the "Registration Statement")** |
|  | **File No. 333-292388** |

---

Ladies and Gentlemen:

The Company hereby withdraws its request for an accelerated effective date of the above-referenced Registration Statement to 5:00 p.m. Eastern Time on January 8, 2026, or as soon as practicable thereafter.

In addition, the Company hereby requests that the effective date of the above-referenced Registration Statement be accelerated to 5:00 p.m. Eastern Time on January 13, 2026, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time pursuant to Rule 461 under the Securities Act of 1933, as amended.

Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by contacting Christian Lichtenberger, Esq. at (212) 997-0962 or <u>clichtenberger@srfc.law.</u>

---

| |
|:---|
| Very truly yours, |
| */s/ William V. Williams* |
| William V. Williams |
| Chief Executive Officer |

---